Ligand Announces Proposed Offering of $650 Million of Convertible Senior Notes
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced
today that it intends to offer, subject to market conditions and other
factors, $650 …
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced
today that it intends to offer, subject to market conditions and other
factors, $650 ...